Provincial Respiratory Surveillance Report

COVID-19 and Seasonal Influenza

2022-2023


This weekly report provides a current epidemiological update on the intensity and severity of respiratory activity in Manitoba including laboratory confirmed activity of both COVID-19 and seasonal influenza. Surveillance data include syndromic indicators, laboratory testing, associated hospitalization and mortality, and outbreaks. Updates around immunization coverage in COVID-19 and seasonal influenza are also included.

Data are reported with a one-week delay for increased data accuracy, completeness and reliability. More analyses continue to be conducted and will be added to this report as available. It is published online at approximately 10:00am every Friday.

Week 46 (November 13 – November 19)

About epidemiological week

Data extracted up to 1:00 am on November 24, 2022
Next reporting date: December 2, 2022

COVID-19 vaccination / Seasonal Influenza vaccination

COVID-19: Similar Activity

COVID-19 activity in Week 46 was similar to the previous week. COVID-19 associated hospital admissions decreased from week 45. Laboratory detections were substantively lower compared to the same time period in the previous two years. Older adults continue to be at higher risk for COVID-19 infections and associated hospital admissions and fatalities.

As of November 19, in all Manitoba residents, 78.1% have received at least two doses of COVID-19 vaccines. Additionally, 21.9% have received at least one dose within the last six months.

Wastewater surveillance data for the city of Winnipeg by November 17 indicated sustained activity of COVID-19.

Cases

About cases

  • Cases this week: 314
  • Total cases: 5632
More Analyses

Testing

About testing

This week

  • Average daily specimens: 388
  • Weekly positivity rate: 18.2%

Total

  • Tested people: 28,632
  • Population tested: 2%
  • Specimens tested: 43,691
  • Positivity rate: 22.0%
More Analyses

Severity

About associated severity

Severe outcomes this week

  • Hospital admissions: 82
    • ICU admissions3: 12
  • Deaths: <5

Total severe outcomes

  • Hospital admissions: 1,836
    • ICU admissions: 201
  • Deaths: 175
More Analyses

Outbreaks

About outbreaks

COVID-19 outbreaks this week

  • In long-term care facilities: 4
  • In hospitals: 4
  • In other settings: 0

Total COVID-19 outbreaks

  • In long-term care facilities: 149
  • In hospitals: 72
  • In other settings: 1
More Analyses

Seasonal Influenza: Increased Activity

Influenza activity increased in the last three weeks. In Week 46, influenza A test positivity increased to 15.6%, lower than 19.2% that was observed nationally. This increase in activity is earlier than would be expected for this time of year. The predominant circulating strain is influenza A (H3N2). Up to Week 46 this season, approximately 40% of those influenza cases and influenza associated hospital admissions are among children below the age of 18. Additionally, children below the age of five years accounted for 15% of all influenza cases and 20% of associated hospital admissions.

At the same time, there are other co-circulating respiratory viruses whose detections have also increased. RSV test positivity was 5.6% in Week 46, similar to 5.5% in the previous week.

Cases

Cases this week

  • Influenza A: 154
  • Influenza B: 0

Total cases

  • Influenza A: 310
  • Influenza B: <5
More Analyses

Testing

Influenza testing this week

  • Average daily specimens: 160
  • Influenza A positivity rate: 15.6%
  • Influenza B positivity rate: 0

Other respiratory pathogens

  • RSV4 positivity rate: 5.6%
  • RSV detections: 62
More Analyses

Severity

Severe outcomes this week

  • Hospital admissions: 14
    • ICU admissions: <5
  • Deaths: <5

Total severe outcomes

  • Hospital admissions: 52
    • ICU admissions: <5
  • Deaths: <5
More Analyses

Outbreaks

Influenza outbreaks this week

  • Influenza A: 4
  • Influenza B: 0

Total influenza outbreaks

  • Influenza A: 9
  • Influenza B: 0
More Analyses

Syndromic Indicators: Increased Activity

The activity level in all syndromic indicators has increased in the last few weeks indicating an increase in respiratory activity in the community and in primary care.

In addition, the daily respiratory related visits to emergency departments/urgent care continued to increase in week 46. Additionally, average daily admissions to hospitals from those respiratory patients in Winnipeg also continued to increase.

FluWatchers

About FluWatchers

Participants reporting: 610

Reporting fever and cough: 2.3%

More Analyses

Physician Visits

About sentinel physicians

Influenza Like Illness (ILI) Visits to sentinel physicians this week: 3.8%

More Analyses

Antiviral

About Antiviral

Units of antiviral dispensed from pharmacies: 13


Total influenza isolates resistant to antiviral this season in Canada

  • Oseltamivir: 0
  • Zanamivir: 0
More Analyses

ED Visits

About emergency room visits

Total respiratory visits to emergency department (ED): 2389

Important Notes

  1. Data about COVID-19 and influenza cases are extracted from PHIMS.
  2. Numbers are subject to change. Missed events in the current report due to reporting delays will be included in later reports when data become available. Cumulative totals include all events from start of the current season to end of the reporting week.
  3. ICU admissions were included in hospital admissions, and include adult and pediatric cases.
  4. RSV - Respiratory syncytial virus.

COVID-19

Cases

Figure 1. Cases of COVID-19 by Week of Public Health Report Date, Manitoba, July 3, 2022 – November 19, 2022

Back


Figure 2. Sex and Age Distribution of COVID-19 Cases, Manitoba, July 3, 2022 – November 19, 2022

Back


Figure 3. Incidence Rate (/10,000 Population) of COVID-19 Cases by Age Group and Week of Public Health Report Date, Manitoba, July 3, 2022 – November 19, 2022

Back


Figure 4. Cases of COVID-19 by Health Region and Public Health Report Date, Manitoba, August 1, 2022 – November 19, 2022

Back


Table 1. Cases of COVID-19 and Incidence Rate (/10,000 population) by Health Region, Manitoba, July 3, 2022 – November 19, 2022

Helath region Total cases Cases this week Incidence rate this week Age-standardized incidence rate* this week
Winnipeg RHA 3546 181 2.3 2.2
Southern Health-Santé Sud 545 28 1.3 1.5
Interlake-Eastern RHA 650 22 1.6 1.5
Prairie Mountain Health 795 57 3.3 2.9
Northern Health Region 408 26 3.4 3.9

Note: * Age-standardized rates are used to account for differences in the age structure in health regions. The whole Manitoba population is used as the standard population.

Back


Testing

Figure 5. Average Daily Testing Volume and Positivity (%) for COVID-19 by Week of Specimen Receiving Date, Manitoba, July 3, 2022 – November 19, 2022

Back


Severity

Figure 6. Severe Outcomes of COVID-19 by Week of Outcome Date, Manitoba, July 3, 2022 – November 19, 2022

Note. ICU admissions are not included in the hospital admissions.

Back


Figure 7. Age Distribution of Severe COVID-19 Cases Compared to All Cases, Manitoba, July 3, 2022 – November 19, 2022

Back


Outbreaks

Figure 8. Weekly COVID-19 Outbreaks, Manitoba, 2020 – 2022

Note: Respiratory outbreaks include COVID-19 outbreaks, influenza outbreaks and the other respiratory outbreaks with known or unknown pathogens.

Back

Vaccination

Table 2. Coverage of COVID-19 Vaccinations, Manitoba, November 19, 2022

Age group (years) At least 1 dose At least 2 doses At least 1 dose within the last 6 months At least 1 dose of Bivalent
.5-04 8.5% 2.7% 8.5% 0.0%
05-11 56.1% 42.8% 9.1% 0.1%
12-17 82.9% 78.4% 9.0% 3.3%
18-29 88.7% 85.7% 6.7% 4.9%
30-39 84.6% 82.1% 10.9% 8.8%
40-49 87.9% 86.1% 14.7% 12.1%
50-59 87.1% 85.8% 25.5% 14.4%
60-69 94.7% 93.5% 45.5% 25.6%
70-79 >=95% >=95% 62.6% 35.3%
80+ >=95% >=95% 62.9% 36.8%
ALL 81.4% 78.1% 21.9% 12.6%

For more information, please visit COVID-19 vaccination coverage in Canada - Canada.ca

Back

Seasonal Influenza

Cases

Figure 9. Weekly Cases of Laboratory-Confirmed Influenza, Manitoba, 2018 – November 19, 2022

Back


Table 3. Cases of Influenza and Incidence Rate (/10,000 population) by Health Region, Manitoba, July 3, 2022 – November 19, 2022

Helath region Total cases Cases this week Incidence rate this week Age-standardized incidence rate* this week
Winnipeg RHA 189 82 1.0 1.1
Southern Health-Santé Sud 31 16 0.7 0.7
Interlake-Eastern RHA 26 16 1.2 1.2
Prairie Mountain Health 48 33 1.9 1.8
Northern Health Region 17 7 0.9 1.1

Note: * Age-standardized rates are used to account for differences in the age structure in health regions. The whole Manitoba population is used as the standard population.

Back


Testing

Figure 10. Average Daily Testing Volume and Positivity (%) for Influenza by Week of Specimen Receiving Date, Manitoba, July 3, 2022 – November 19, 2022

Back


Figure 11. Number of Positive Respiratory Virus Tests by Week of Specimen Receiving Date, Manitoba, July 3, 2022 – November 19, 2022

Note. Other respiratory viruses include adenovirus, enterovirus/rhinovirus, human coronavirus (seasonal), human metapneumovirus and human parainfluenza virus.

Back


Figure 12. Age Distribution of Severe Influenza Cases Compared to All Cases, Manitoba, July 3, 2022 – November 19, 2022

Back


Outbreaks

Figure 13. Weekly Respiratory and Influenza Outbreaks, Manitoba, 2018 – November 19, 2022

Note: Respiratory outbreaks include COVID-19 outbreaks, influenza outbreaks and the other respiratory outbreaks with known or unknown pathogens.

Back


Vaccinations

Table 5. Coverage of Influenza Vaccinations, Manitoba, September 1, 2022 – November 19, 2022

Age group Does Coverage percentage
0-4 7357 8.7%
5-17 19401 8.5%
18-49 59829 10.1%
50-64 58044 22.4%
65+ 115823 49.5%
All 261866 18.7%

Back


FluWatchers

Figure 14. Weekly FluWatchers Participants and Percentage Reporting Fever and Cough, Manitoba, 2018 – November 19, 2022

Back


Physician Visits

Figure 15. Weekly Percentage of ILI Related Visits to Sentinel Physicians, Manitoba, 2018 – November 19, 2022

Back


Antiviral

Figure 16. Weekly Units of Antiviral Dispensed from Pharmacies, Manitoba, 2018 – November 19, 2022

Back